Резолюция совета экспертов по проблемам терапии множественной миеломы в условиях пандемии COVID-19
Журнал: Вестник гематологии @bulletin-of-hematology
Рубрика: Новости
Статья в выпуске: 2 т.16, 2020 года.
Бесплатный доступ
Короткий адрес: https://sciup.org/170171861
ID: 170171861
Список литературы Резолюция совета экспертов по проблемам терапии множественной миеломы в условиях пандемии COVID-19
- Бессмельцев С. С., Абдулкадыров К. М. Множественная миелома: руководство для врачей. - М.: МК, 2016.- 504 с.
- European Society of Medical Oncology. ESMO management and treatment adapted recommendations in the COVID-19 era: multiple myeloma. // https:www.esmo.org/guidelines/cancer-patient-managementduring-the-covid-19 pandemi
- UK Myeloma Forum guidance to support medical decisionmaking in the management of myeloma patients during the COVID-19 (Coronavirus) outbreak (25 March 2020). Accessed 19 April 2020.
- Terpos E., Engelhardt M., Cook G. et al. Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN) // Leukemia. https: DOI: 10.1038/s41375-020-0876-z
- International Myeloma Society. International Myeloma Society Recommendations for the Management of Myeloma Patients During the COVID-19 Pandemic. https://cms. cws. net/content/beta. myelomasociety. org/files/IMS %20recommendations%20for%20Physicians%20Final. pdf Accessed 19 April 2020.
- Mian H., Grant S. J., Engelhardt M. et al. Caring for older adults with multiple myeloma during the COVID-19 Pandemic: Perspective from the International Forum for Optimizing Care of Older Adults with Myeloma. // J Geriatri Oncol. - 2020. pii: S1879-4068(20)30190-9. https: doi. org/10.1016/j. jgo.2020.04.008. DOI: 10.1016/j.jgo.2020.04.008
- Вe Paula B. H. R., Araujo I., Bandeira L. et al. Recommendations from national regulatory agencies for ongoing cancer trials during the COVID-19 pandemic.// Lancet Oncol. - 2020. - Vol. 21. - P. 624-627.
- Rajkumar S., Cavo M., Mikhail J. et al. COVID-19 and Multiple myeloma: frequently asked questions (Version 1.0. last reviewed April 7, 2020). https://www. hematology.org/covid-19/covid-19-and-multiple-myeloma Accessed 19 April 2020
- Moreau P., Masszi T., Grzasko N. et al. Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma. // N Engl J Med. - 2016. - Vol. 374, N17. - P. 1621-1634.
- Liang W., Guan W., Chen R. et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. // Lancet Oncol. - 2020. - Vol. 21. - P. 335-337.
Другой
